The isokinetic muscle strength in 56 IDDM patients with > 20 years of
diabetes duration and in their individually sex-, age-, weight-, and h
eight-matched control subjects was assessed. Peak torque of foot dorsa
l and plantar flexion and knee and wrist extension and flexion was mea
sured. The neuropathic condition was assessed by a neurological disabi
lity score, a neuropathy symptom score, nerve conduction studies, and
quantitative sensory examination. All results were summed to obtain a
neuropathy rank-sum score for each patient. According to their renal a
lbumin excretion, the patients were classified to have normo-, micro-,
or macroalbuminuria. In addition, according to their retinal status,
patients were classified as having no, simple, or proliferative retino
pathy. The IDDM patients had a 21% reduction of muscle strength of bot
h ankle dorsal (P < 1 x 10(-4)) and plantar flexors (P < 0.01), compar
ed with control subjects. A 16% reduction of knee extensors (P < 0.005
) and a 17% reduction of knee flexors (P < 0.01) was found. In contras
t, muscle strength in wrist flexors and extensors was not significantl
y reduced (10 and 11%, respectively [NS]). In patients with the most s
evere weakness, muscle strength of the calf muscles was only 50% of th
e expected performance. Correlations were found between the neuropathy
rank-sum score and the muscle strength of ankle dorsal (r = -0.66, P
< 1 x 10(-7)) and plantar flexors (r = -0.51, P < 0.0005)), knee exten
sors (r = -0.51, P < 0.0005) and flexors (r = -0.44, P < 0.005), and w
rist flexors (r = -0.41, P < 0.005). No correlation was found for wris
t extensors (r = 0). Neither were there any relationships between musc
le strength at the ankle and knee and the degree of albuminuria or ret
inopathy. In conclusion, motor performance is substantially impaired i
n long-term IDDM patients, and the weakness is related to the presence
of neuropathy but not to albuminuria or retinopathy per se.